What do systematic reviews say?

Summary of findings table (subcomparison 5): chemotherapy or targeted therapy agent(s) plus control intervention vs control intervention

• Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer 2017 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 1870 participants
  Very low

Bisphosphonates vs placebo/no treatment

The review found no eligible studies for this question.

• Bisphosphonates for advanced prostate cancer 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Transobturator (TOR) vs retropubic (RPR) route

• Mid‐urethral sling operations for stress urinary incontinence in women 2017 · Cochrane Headline outcomes only
  no estimate extracted
  11 studies · 11 participants
  GRADE not reported

Obturator medial‐to‐lateral approach vs obturator lateral‐to‐medial approach

• Mid‐urethral sling operations for stress urinary incontinence in women 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 46 participants
  Very low

Music vs usual care

• Music interventions for acquired brain injury 2017 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 53 participants
  Low

Intervention not reported

The review found no eligible studies for this question.

• Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 1298 participants
  Moderate

Intervention not reported

The review found no eligible studies for this question.

• Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The intervention probably leads to lower quality of life (moderate certainty).

• Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 2258 participants
  Moderate

Intervention not reported

The review found no eligible studies for this question.

• Stretch for the treatment and prevention of contractures 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Cognitive rehabilitation vs no treatment

• Cognitive rehabilitation for adults with traumatic brain injury to improve occupational outcomes 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 98 participants
  Low

Escalated BEACOPP vs chemotherapy including ABVD

The review found no eligible studies for this question.

• Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with… 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Virtual reality vs conventional therapy

• Virtual reality for stroke rehabilitation 2017 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 300 participants
  Low

Intervention not reported

• Deep brain and cortical stimulation for epilepsy 2017 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Combinations of antipsychotic drugs vs single antipsychotic drugs

• Antipsychotic combinations for schizophrenia 2017 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 398 participants
  GRADE not reported